½ÉÀå´ë»çÁõÈıºÇÐȸ 2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷) : 2022-04-29±³À°ÀÏÀÚ : 2022-04-29
±³À°Àå¼Ò : Conrad Hotel Seoul (5F PARK BALLROOM)
±³À°ÁÖÁ¦ :
2022 5th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS(1ÀÏÂ÷)ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ
´ã´çÀÚ : ±è¼±¿Á
¿¬¶ôó : 02-2273-8556
À̸ÞÀÏ :
apcms@kscms.org ±³À°Á¾·ù : ³»°ú
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 200,000¿ø
ºñ°í Á¶±â»çÀüµî·Ï/Á¤±Ô»çÀüµî·Ï/ÇöÀåµî·Ï(Foreign:50USD)(Domestic M.D. / Ph.D.:180,000/190,000/200,000 KRW)(Domestic Student/Nurse/Medical Representatives/Resident, etc.:30,000KRW)
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-29 Room 1 09:00~09:16 Associations Between Body Fat Parameters and Arterial Stiffness ±èÇзÉ(¼¿ïÀÇ´ë)
±³À°½Ã°£ 04-29 Room 1 09:16~09:32 Predictors of Metabolic Syndrome in Patients With RA: Clinic Based Case-Control Study Shukhrat Ziyadullaev(Samarkand State Medical Inst. Uzbekistan)
±³À°½Ã°£ 04-29 Room 1 09:32~09:48 Knowledge, Attitude, Practice and Awareness on Complications of Hypertension Among Students and Staff in Faculty of Medicine and Health Sciences Navin Kumar Devara(Univ. Putra Malaysia Malaysia)
±³À°½Ã°£ 04-29 Room 1 09:48~10:04 Effects of Zinc Oxide Nanoparticles on Oxidative Stress and Renal Function in Fat-Fed and Streptozotocin-Treated Rats Pardeep Kumar(F H Medical College India)
±³À°½Ã°£ 04-29 Room 1 10:04~10:20 Hemo-Metabolic Crisis in Patients With ST-Segment Elevation Myocardial Infarction Data From INTERSTELLA Registry °ø¹Î±Ô(¼øõÇâÀÇ´ë)
Åä·Ð 04-29 Room 1 10:20~10:40 Discussion ¿À±Ôö(Ä«Å縯ÀÇ´ë)
±³À°½Ã°£ 04-29 Room 1 11:00~11:20 PCSK9 Inhibitors ±âÀ¯Á¤(À»ÁöÀÇ´ë)
±³À°½Ã°£ 04-29 Room 1 11:20~11:40 Recent Insights of SGLT2 Inhibitors in the Care of Cardiometabolic Syndrome Atsushi Tanaka(Saga Univ. Japan)
±³À°½Ã°£ 04-29 Room 1 11:40~11:50 GLP-1RA ±è¿øÁø(Â÷ÀÇ°ú´ëÇÐ)
±³À°½Ã°£ 04-29 Room 1 11:50~12:00 ARNI ¹ÚÁøÁÖ(¼¿ïÀÇ´ë)
Åä·Ð 04-29 Room 1 12:00~12:20 Discussion ¹®Àαâ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04-29 Room 1 13:25~14:05 New Approaches to Treating Metabolic Diseases and CVD Based on Clinical Trials Robert H. Eckel(Univ. of Colorado USA)
Åä·Ð 04-29 Room 1 14:05~14:25 Q&A Robert H. Eckel(Univ. of Colorado USA)
±³À°½Ã°£ 04-29 Room 1 14:30~14:45 Statin À̹ÎÈ£(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04-29 Room 1 14:45~15:00 PCSK-9 Inhibitors ÃÖ¼ºÈÆ(ÇѸ²ÀÇ´ë)
±³À°½Ã°£ 04-29 Room 1 15:00~15:15 Ezetimibe Á¤ÀçÈÆ(±¹¸³Áß¾ÓÀÇ·á¿ø)
±³À°½Ã°£ 04-29 Room 1 15:15~15:30 Colchicine ¹ÚÈÆÁØ(°¡Å縯ÀÇ´ë)
Åä·Ð 04-29 Room 1 15:30~15:45 Discussion ±âÀ¯Á¤(À»ÁöÀÇ´ë)
±³À°½Ã°£ 04-29 Room 1 16:00~16:40 Remnant Cholesterol B©ªrge Nordestgaard(Univ. of Copenhagen Denmark)
Åä·Ð 04-29 Room 1 16:40~16:45 Q&A B©ªrge Nordestgaard(Univ. of Copenhagen Denmark)
±³À°½Ã°£ 04-29 Room 1 16:50~17:05 Home BP Monitoring ¹ÚÀçÇü(Ãæ³²´ë)
±³À°½Ã°£ 04-29 Room 1 17:05~17:20 Management of Young Age Hypertension ±èÇöâ(¿¬¼¼ÀÇ´ë)
±³À°½Ã°£ 04-29 Room 1 17:20~17:35 Thiazide vs Thiazide-Like: Which Diuretic Should We Choose? ¾ÈÈ¿¼®(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04-29 Room 1 17:35~17:50 Digital therapy on hypertension ÀÌÇØ¿µ(¼¿ïÀÇ´ë)
Åä·Ð 04-29 Room 1 17:50~18:05 Discussion ±è¹Î°ü(¿¬¼¼ÀÇ´ë)